Abstract
AbstractSyrup of ipecac is an excellent drug for the treatment of poisonings. It is universally recommended that ipecac be kept in homes where there are young children, but a risk/benefit analysis of this recommendation has never been performed. We report two cases of alkali ingestions in which ipecac syrup was inappropriately administered at home. These vignettes demonstrate the need to reexamine current policies of dispensing and distributing ipecac. Even though most families would probably benefit from having ipecac syrup at home, it must be questioned whether ipecac should be universally prescribed. Variables such as level of understanding, social disruption, and access to pharmacies and emergency rooms should be considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
